Glenmark Pharmaceuticals Q1 Results
- BSE: 532296
- NSE: GLENMARK
- ISIN: INE935A01035
- Sector: Biotechnology & Drugs
BSE
2,204.15
25.60 (1.18%)
25.60 (1.18%)Volume21.63 K
Updated: Tue 9 Jun, 2026 | 15:25:28
NSE
2,209.6033.10 (1.52%)
33.10 (1.52%)Volume5.61 L
Updated: Tue 9 Jun, 2026 | 15:40:20
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Quarter ended Jun 25
Note: Comparison is on QoQ basis
Quarterly - Glenmark Pharmaceuticals Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 25 | Mar 26 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 3,137.08 | 3,529.30 | -1.76% | 2,773.76 | 13.10% |
| Depreciation/ Amortization | 129.93 | 147.91 | 3.77% | 117.79 | 10.30% |
| Operating Income | 127.36 | 241.29 | 102.16% | 470.42 | -72.93% |
| Net Income | 46.87 | 301.41 | 907.98% | 340.27 | -86.23% |
| Other Operating Expenses Total | 905.59 | 948.27 | 4.13% | 835.45 | 8.40% |
| Net Income Before Taxes | 95.58 | 387.77 | 1098.62% | 462.33 | -79.33% |
| Total Revenue | 3,264.44 | 3,770.59 | 0.25% | 3,244.19 | 0.62% |
| Selling/ General/ Admin Expenses Total | 762.75 | 887.44 | 3.55% | 710.44 | 7.36% |
| Diluted Normalized EPS | 7.29 | 20.96 | -1.90% | 12.06 | -39.58% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.